Loading...
XNYS
DOC
Market cap9.63bUSD
Jun 10, Last price  
17.60USD
Name

Healthpeak Properties Inc

Chart & Performance

D1W1MN
No data to show
P/E
39.61
P/S
3.57
EPS
0.44
Div Yield, %
1.70%
Shrs. gr., 5y
28.69%
Rev. gr., 5y
45.42%
Revenues
2.70b
+23.82%
13,847,00012,946,89916,799,00053,334,000129,441,000241,034,000343,584,000422,551,000415,281,000437,505,000457,699,000526,635,0002,181,003,0002,700,449,000
Net income
243m
-20.54%
-3,060,000-1,655,607-2,237,000-4,037,00011,788,00029,981,00038,146,00056,230,0009,489,00010,195,00025,399,00037,802,000306,009,000243,142,000
CFO
1.07b
+11.95%
2,978,0003,360,1351,005,00013,295,00061,352,000124,779,000180,471,000208,694,000201,177,000233,297,000247,555,000258,400,000956,242,0001,070,497,000
Dividend
Feb 14, 20240.3 USD/sh

Profile

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
URL
https://www.healthpeak.com/
IPO date
May 23, 1985
Employees
199
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,700,449
23.82%
2,181,003
314.14%
526,635
15.06%
Cost of revenue
1,172,023
1,005,795
219,209
Unusual Expense (Income)
NOPBT
1,528,426
1,175,208
307,426
NOPBT Margin
56.60%
53.88%
58.38%
Operating Taxes
4,350
(9,617)
72,234
Tax Rate
0.28%
23.50%
NOPAT
1,524,076
1,184,825
235,192
Net income
243,142
-20.54%
306,009
709.50%
37,802
48.83%
Dividends
(794,783)
(657,021)
(649,364)
Dividend yield
Proceeds from repurchase of equity
(190,373)
(6,246)
99,278
BB yield
Debt
Debt current
150,000
23,974
188,328
Long-term debt
9,180,489
7,282,761
1,839,811
Deferred revenue
940,136
905,633
21,062
Other long-term liabilities
191,884
467,876
(361,389)
Net debt
8,273,857
6,384,888
1,942,693
Cash flow
Cash from operating activities
1,070,497
956,242
258,400
CAPEX
(39,869)
Cash from investing activities
(113,799)
(576,754)
(38,472)
Cash from financing activities
(941,416)
(337,299)
(222,074)
FCF
444,710
1,902,205
140,620
Balance
Cash
119,818
138,994
7,730
Long term investments
936,814
782,853
77,716
Excess cash
921,610
812,797
59,114
Stockholders' equity
1,384,651
(8,102,771)
(746,767)
Invested Capital
18,291,303
22,481,570
5,303,374
ROIC
7.48%
8.53%
4.29%
ROCE
7.96%
8.18%
6.25%
EV
Common stock shares outstanding
676,233
547,275
539,147
Price
Market cap
EV
EBITDA
2,585,631
1,925,109
497,067
EV/EBITDA
Interest
280,430
200,331
72,234
Interest/NOPBT
18.35%
17.05%
23.50%